Literature DB >> 16574934

Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease.

Charles S Berenson1, Catherine T Wrona, Lori J Grove, Jane Maloney, Mary Alice Garlipp, Paul K Wallace, Carleton C Stewart, Sanjay Sethi.   

Abstract

RATIONALE: Interactions of nontypeable Haemophilus influenzae (NTHI) with macrophages are implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, the immunologic mechanisms that mediate NTHI-macrophage inflammation are poorly understood. Outer membrane protein (OMP) P6 and lipooligosaccharide (LOS) of NTHI are potent immunomodulators. We theorized that alveolar macrophages in COPD possess fundamental immune defects that permit NTHI to evade host responses.
OBJECTIVE: To test this hypothesis, we obtained human alveolar and blood macrophages from exsmokers with COPD, exsmokers without COPD, and nonsmokers.
METHODS: Alveolar and blood macrophages from each donor were incubated with purified LOS and OMP P6 and with OMP P2 and the total outer membrane preparation (0.1-1 microg/ml). MEASUREMENTS: Supernatants (24 h) were assayed for IL-1beta, TNF-alpha, IL-10, IL-12, and IL-8 by multianalyte multiplexed flow cytometry.
RESULTS: Comparative induction of COPD and non-COPD alveolar macrophages by LOS and OMP P6 revealed diminished IL-8, TNF-alpha, and IL-1beta responses of COPD alveolar macrophages (p < or = 0.03 for each). COPD alveolar macrophages also had diminished responses to total outer membrane (p < or = 0.03 for each). In contrast, COPD blood macrophages had no significant differences among donor groups in IL-8, TNF-alpha, or IL-1beta responsiveness to NTHI antigens. Diminished IL-12 responses of COPD blood macrophages to NTHI antigens, compared with nonsmokers, could not be independently dissociated from group differences in age and pack-years.
CONCLUSIONS: These findings support a paradigm of defective immune responsiveness of alveolar macrophages, but not blood macrophages, in COPD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574934      PMCID: PMC2662920          DOI: 10.1164/rccm.200509-1461OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  41 in total

1.  Purification and analysis with monoclonal antibodies of P2, the major outer membrane protein of nontypable Haemophilus influenzae.

Authors:  T F Murphy; L C Bartos
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

2.  Gangliosides of monocyte-derived macrophages of adults with advanced HIV infection show reduced surface accessibility.

Authors:  C S Berenson; M A Gallery; M S Katari; E W Foster; M A Pattoli
Journal:  J Leukoc Biol       Date:  1998-09       Impact factor: 4.962

3.  Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines.

Authors:  Charles S Berenson; Timothy F Murphy; Catherine T Wrona; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide.

Authors:  C Dinakar; A Malur; B Raychaudhuri; L T Buhrow; A L Melton; M S Kavuru; M J Thomassen
Journal:  Ann Allergy Asthma Immunol       Date:  1999-02       Impact factor: 6.347

5.  Specific binding of Haemophilus influenzae to minor gangliosides of human respiratory epithelial cells.

Authors:  M G Fakih; T F Murphy; M A Pattoli; C S Berenson
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  Type b capsule inhibits ingestion of Haemophilus influenzae by murine macrophages: studies with isogenic encapsulated and unencapsulated strains.

Authors:  G J Noel; S K Hoiseth; P J Edelson
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

7.  Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae.

Authors:  A A Campagnari; M R Gupta; K C Dudas; T F Murphy; M A Apicella
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

8.  Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse.

Authors:  Andrew Churg; Rong D Wang; Hsin Tai; Xiaoshan Wang; Changshi Xie; Joanne L Wright
Journal:  Am J Respir Crit Care Med       Date:  2004-06-07       Impact factor: 21.405

9.  Phagocytosis and killing of Haemophilus influenzae by alveolar macrophages: no difference between smokers and non-smokers.

Authors:  S Jonsson; D M Musher; E C Lawrence
Journal:  Eur J Respir Dis       Date:  1987-05

10.  Characterization of a population of small macrophages in induced sputum of patients with chronic obstructive pulmonary disease and healthy volunteers.

Authors:  M Frankenberger; M Menzel; R Betz; G Kassner; N Weber; M Kohlhäufl; K Häussinger; L Ziegler-Heitbrock
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

View more
  44 in total

1.  Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.

Authors:  Christopher J Harvey; Rajesh K Thimmulappa; Sanjay Sethi; Xiaoni Kong; Lonny Yarmus; Robert H Brown; David Feller-Kopman; Robert Wise; Shyam Biswal
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

2.  Oxidized phospholipid, 1-palmitoyl-2-(9'-oxo-nonanoyl)-glycerophosphocholine (PON-GPC), produced in the lung due to cigarette smoking, impairs immune function in macrophages.

Authors:  Tomomi Kimura; Yoko Shibata; Keiko Yamauchi; Akira Igarashi; Sumito Inoue; Shuichi Abe; Kazuhiro Fujita; Yoichi Uosaki; Isao Kubota
Journal:  Lung       Date:  2011-10-11       Impact factor: 2.584

3.  Immunity status of invasive pulmonary aspergillosis patients with structural lung diseases in Chinese adults.

Authors:  Shuo Liang; Rong Jiang; Hai-Wen Lu; Bei Mao; Man-Hui Li; Cheng-Wei Li; Shu-Yi Gu; Jiu-Wu Bai; Jin-Fu Xu
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

4.  The anti-inflammatory effects of PGE2 on human lung macrophages are mediated by the EP4 receptor.

Authors:  Sharonjit K Gill; Yiwen Yao; Linda J Kay; Martin A Bewley; Helen M Marriott; Peter T Peachell
Journal:  Br J Pharmacol       Date:  2016-09-06       Impact factor: 8.739

5.  Chronic Obstructive Pulmonary Disease: Abandoning the "Streetlight Effect".

Authors:  Venkataramana K Sidhaye; Shyam Biswal
Journal:  Am J Respir Crit Care Med       Date:  2018-09-15       Impact factor: 21.405

6.  Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.

Authors:  Charles S Berenson; Ragina L Kruzel; Ellana Eberhardt; Sanjay Sethi
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

7.  Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.

Authors:  J M Löfdahl; J Wahlström; C M Sköld
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

8.  Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages.

Authors:  H J Metcalfe; S Lea; D Hughes; R Khalaf; K Abbott-Banner; D Singh
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

9.  Repetitive organic dust exposure in vitro impairs macrophage differentiation and function.

Authors:  Jill A Poole; Neil E Alexis; Conrad Parks; Amy K MacInnes; Martha J Gentry-Nielsen; Paul D Fey; Lennart Larsson; Diane Allen-Gipson; Susanna G Von Essen; Debra J Romberger
Journal:  J Allergy Clin Immunol       Date:  2008-06-27       Impact factor: 10.793

Review 10.  Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Tariq A Bhat; Louis Panzica; Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Ann Am Thorac Soc       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.